As more employers invest in fertility-related benefits, they are focusing on such offerings as fertility medications, in-vitro fertilization and non-IVF treatments.
Since the pandemic, top HR leaders have increasingly encountered hesitation from potential successors. They are dipping into less experienced, early-career candidates for the CHRO slot, HR experts say.
The FDA's decision on Aug. 9, 2024, not to approve MDMA to treat PTSD marks a blow to a small but growing number of employers offering healthcare coverage for psychedelic drugs to treat mental health issues like depression.
